Polaryx Therapeutics, Inc <PLYX.O>: Raymond James initiates coverage with Strong Buy rating; target price $6
PLYX•Related News
Allstate CFO Christian M. Lown files initial beneficial ownership statement
ALL•
Standard Lithium works with Nano One on LFP cathode, cell testing using Arkansas lithium carbonate
SLI•
Phinia publishes 2025 sustainability report, cites 35% drop in Scope 1-2 emissions intensity in 2025
PHIN•
Valvoline launches USD 500 million senior notes offering due 2034
VVV•
GameSquare names Tom Wild VP of Creative Strategy for EMEA
GAME•